CNBC | Marathon charges $89000 a year for new new muscular dystrophy drug CNBC A patient with Duchenne muscular dystrophy controls a motorized wheelchair. DMD afflicts about 1 in 3,500 boys worldwide. The U.S. Food and Drug Administration last week approved a drug made by Marathon Pharmaceuticals to treat Duchenne muscular … Marathon to charge $89000 for DMD drug after 70-fold increase This drug just got the FDA's OK — and an $89K price tag What We're Reading: DMD Drug Gets $89K Price Tag; Necessary Drug Price Hikes; and ACA Taxes |
Marathon charges $89000 a year for new new muscular dystrophy drug – CNBC added by admin on
View all posts by admin →
You must be logged in to post a comment Login